Attached files

file filename
EX-10.73 - NON-EMPLOYEE DIRECTORS COMPENSATION PROGRAM - AETHLON MEDICAL INCaethlon_ex1073.htm
EX-32.2 - CERTIFICATION - AETHLON MEDICAL INCaethlon_ex3202.htm
EX-31.2 - CERTIFICATION - AETHLON MEDICAL INCaethlon_ex3102.htm
EX-31.1 - CERTIFICATION - AETHLON MEDICAL INCaethlon_ex3101.htm
EX-23.1 - CONSENT - AETHLON MEDICAL INCaethlon_ex2301.htm
EX-14 - CODE OF ETHICS - AETHLON MEDICAL INCaethlon_ex1400.htm
EX-10.84 - FORM OF EXCHANGE AGREEMENT - AETHLON MEDICAL INCaethlon_ex1083.htm
EX-10.80 - FOURTH AMENDMENT TO STANDARD INDUSTRIAL NET LEASE - AETHLON MEDICAL INCaethlon_ex1080.htm
EX-10.79 - STOCK UNIT AGREEMENT - SHAH - AETHLON MEDICAL INCaethlon_ex1079.htm
EX-10.78 - STOCK UNIT AGREEMENT - BROENNIMAN - AETHLON MEDICAL INCaethlon_ex1078.htm
EX-10.77 - STOCK UNIT AGREEMENT - BARRY - AETHLON MEDICAL INCaethlon_ex1077.htm
EX-10.76 - STOCK UNIT AGREEMENT - FRAKES - AETHLON MEDICAL INCaethlon_ex1076.htm
EX-10.75 - STOCK UNIT AGREEMENT - KENLEY - AETHLON MEDICAL INCaethlon_ex1075.htm
EX-10.74 - STOCK UNIT AGREEMENT - JOYCE - AETHLON MEDICAL INCaethlon_ex1074.htm
10-K - FORM 10-K - AETHLON MEDICAL INCaethlon_10k-033117.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Aethlon Medical, Inc. (the “Registrant”) on Form 10-K for the fiscal year ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof, I, James A. Joyce, Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Annual Report on Form 10-K fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

 

2. The information contained in such Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of Aethlon Medical, Inc.

 

   
Dated: June 28, 2017 /s/ JAMES A. JOYCE
  James A. Joyce
  Chief Executive Officer
  Aethlon Medical, Inc.

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Aethlon Medical, Inc. and will be retained by Aethlon Medical, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.